Publications
- First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study
Kreuz W et al. Haemophilia 2016; 22, 87-95
- Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-α and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe Haemophilia A
Pavlova A et al. J Thromb Haemost 2009; 7:2006-2015
- The role of VWF for the success of immune tolerance induction
Kreuz W. Thrombosis Research 2008; 122(Suppl. 2):S7-S12
- The role of VWF in the immunogenicity of FVIII
Lacroix-Desmazes S et al. Thrombosis Research 2008, 122(Suppl. 2):S1-S6
- VWF/FVIII complex and the management of patient with inhibitors: from laboratory to clinical practice
Berntorp E. Haemophilia 2007; 13 Suppl. 5:69-72
International open-label, uncontrolled, non-interventional, multi-centre observational program conducted by the HZRM, Frankfurt-Mörfelden, Germany